StevenRLongMD

Pathology • San Francisco, CA

Cytopathology, Anatomic Pathology, Clinical Pathology

Clinical Professor Pathology, UCSF

Join to view full profile

Dr. Long is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Long's full profile

Already have an account?

Office
1825 4th St
Rm L2181A
San Francisco, CA 94143
Phone+1 415-353-4554

Fax+1 415-353-7676

Education & Training

University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1992 - 1995
University of California San Francisco School of MedicineClass of 1992

Certifications & Licensure

CA State Medical License 1994 - 2025
American Board of Pathology Anatomic Pathology
American Board of Pathology Cytopathology

Publications & Presentations

PubMed

19 citations
Low-grade lymphoma of mucosa-associated tissue in the parotid gland: a case report of fine-needle aspiration cytology diagnosis using flow cytometric immunophenotyping.
Imok Cha, Steven R. Long, Britt-Marie E. Ljung, Theodore R. Miller
Diagnostic Cytopathology. 1997-01-01
127 citations
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma.
Matthew J. Frank, Patrick M. Reagan, Nancy L. Bartlett, Leo I. Gordon, Jonathan W. Friedberg
Cancer Discovery. 2018-08-28
47 citations
Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
Sarah Haebe, Tanaya Shree, Anuja Sathe, Grady Day, Debra K. Czerwinski
Blood. 2021-05-27

Abstracts/Posters

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma
Steven R. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and N...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018